may improve siRNA performance, since dsRBM proteins
such as PKR and the ADARs can impede siRNAs from
causing the desired specific RNAi effect.14-17 New ways of
directing functionality into the minor groove of duplex RNA
will therefore also be of interest in siRNA design.
faster with fluoride leaving groups than other halide leaving
groups,20 we prepared a 2-fluoropurine ribonucleoside pre-
cursor to evaluate it as a substrate for substitution reactions
with various amines (Scheme 1). For the purposes of
comparison, we also investigated a 2-bromopurine ribo-
nucleoside intermediate as an alternative precursor to 2-ami-
nopurine derivatives.
To create new nucleoside analogs that could be used to
modify A•U pairs in RNA with minor groove substituents,
we chose to synthesize derivatives of 2-aminopurine ribo-
nucleoside bearing different substituents at N2 (Figure 1).
Like guanosine, 2-aminopurine in duplex RNA projects the
2-amino group into the minor groove. Furthermore, 2-ami-
nopurine is an effective replacement for adenosine as it is
anticipated to form a stable, two hydrogen bond pair with
uridine. However, there are no reports on the effect of N2-
modified 2-aminopurine ribonucleoside substitution for ad-
enosine in duplex RNA. Here we describe the synthesis of
2-aminopurine ribonucleoside analogs and their phosphora-
midites, their incorporation into RNA, their postsynthetic
modification via Cu-catalyzed azide-alkyne cycloaddition
(CuAAC) and their effect on duplex stability and base pairing
specificity.
We chose to protect the ribose hydroxyl groups of the
2-fluoropurine ribonucleoside intermediate in acetate esters
to allow for convenient deprotection at the amine substitution
step. Thus, 2′,3′,5′-tri-O-acetyl-2-fluoropurine ribonucleoside
(3) was prepared by dehalo hydrogenolysis and diazotization/
fluorination of 2′,3′,5′-tri-O-acetyl-6-chloro-2-aminopurine
(1). The 6-chloro hydrogenolysis substrate was readily
prepared from guanosine via the method of Robins and
Uznanski.21 Hydrogenolysis of 1 has previously been
reported in methanol;22 however, we found the reaction was
more efficient upon addition of 10% THF to the solvent,
delivering 2′,3′,5′-tri-O-acetyl-2-aminopurine (2) in 84%
yield. Diazotization/fluorination of 2 proceeded in excellent
yield to afford the acetyl protected 2-fluoropurine intermedi-
ate. We evaluated the 2-fluoropurine intermediate as a
substrate for SNAr reactions by treating it with amines in
DMF or THF. Cyclopentyl and propyl groups were chosen
for incorporation at N2 in order to investigate the effect of
varying the size of the minor groove obstruction in an RNA
duplex on duplex stability and protein binding. To prepare
RNA amenable to postsynthetic modification via CuAAC
reaction, we also introduced a propargyl group. For the
cyclopentylamine and propylamine substitutions, the substi-
tution reactions occurred rapidly at ambient temperature with
an excess of alkylamine in DMF, consuming the fluoropurine
starting material in less than 30 min. After completion of
the substitution reaction, it was necessary to add NH3/
methanol to the reaction mixture to achieve complete acetyl
deprotection. Chromatographic purification yielded free
nucleoside derivatives 4 and 5 in good yield. The rate of
substitution with propargylamine was slightly slower. After
3 h in THF at 65 °C, the fluoropurine was completely
consumed. Subsequent NH3/methanol treatment and purifica-
tion afforded the desired N2-modified 2-aminopurine ribo-
nucleoside derivative 6 in good yield.
Figure 1. (A) Structure of an A•U base pair in duplex RNA,
showing location of adenosine C2.18 (B) N2-Modified 2-aminopu-
rines place steric bulk (R) in the duplex RNA minor groove.
The SNAr reaction with amines was also investigated using
2′,3′,5′-tri-O-tert-butyldimethylsilyl-2-bromopurine ribonu-
cleoside (8) as a substrate. The bromopurine intermediate
was prepared by diazotization/bromination23 of tri-O-TB-
DMS protected 2-aminopurine ribonucleoside, which was
generated in one step from commercially available 6-mer-
capto-2-aminopurine ribonucleoside.24 SNAr reactions with
excess amine occurred in 1-5 h at 75-80 °C in DMF in
good yields to afford the tri-O-TBDMS N2-modified ribo-
nucleosides 9-14 (Scheme 2). Deprotection to the free
nucleoside was demonstrated on the TBDMS-protected N2-
The preparation of the analog N2, N2-dimethyl-2-aminopu-
rine ribonucleoside has previously been reported via SNAr
reaction between a 2-chloropurine ribonucleoside precursor
and dimethylamine.19 Since SNAr reactions typically proceed
(14) Armstrong, M. E.; Gantier, M.; Li, L. L.; Chung, W. Y.; McCann,
A.; Baugh, J. A.; Donnelly, S. C. J. Immunol. 2008, 180, 7125–7133
(15) Nishikura, K. Nat. ReV. Mol. Cell. Biol. 2006, 7, 919–31
(16) Zhang, Z. R.; Weinschenk, T.; Gu, K. T.; Schluesener, H. J. J. Cell.
Biochem. 2006, 97, 1217–1229
.
.
.
(17) Richardt-Pargmann, D.; Vollmer, J. In Oligonucleotide Therapeu-
tics; Rossi, J. J., Gait, M. J., Eckstein, F., Eds.; Blackwell Publishing:
Oxford, 2009; Vol. 1175, pp 40-54.
(20) Liu, J.; Robins, M. J. J. Am. Chem. Soc. 2007, 129, 5962–8.
(21) Robins, M. J.; Uznanski, B. Can. J. Chem. 1981, 59, 2601–2607.
(22) Zagorowska, I.; Adamiak, R. W. Biochimie 1996, 78, 123–130.
(23) Francom, P.; Robins, M. J. Org. Chem. 2003, 68, 666–669.
(24) Fox, J. J.; Wempen, I.; Hampton, A.; Doerr, I. L. J. Am. Chem.
Soc. 1956, 80, 1669–1675.
(18) Dock-Bregeon, A. C.; Chevrier, B.; Podjarny, A.; Johnson, J.; de
Bear, J. S.; Gough, G. R.; Gilham, P. T.; Moras, D. J. Mol. Biol. 1989,
209, 459–474.
(19) Schaeffer, H. J.; Thomas, H. J. J. Am. Chem. Soc. 1958, 80, 4896–
4899.
Org. Lett., Vol. 12, No. 5, 2010
1045